30th Jul 2015 07:00
30 July 2015
Source BioScience plc
('Source BioScience' or the 'Company')
Posting of Class 1 Circular and Notice of General Meeting
Further to the Company's announcement on 27 July 2015 relating to the proposed acquisition of Select Pharma Laboratories Ltd ('Select') (the 'Acquisition'), the Board of Source BioScience, the international laboratory services and products business, is pleased to announce that a Class 1 Circular incorporating a Notice of General Meeting dated 29 July 2015 (the 'Circular') was yesterday posted to Shareholders.
As detailed in the Circular, the Acquisition constitutes a Class 1 transaction for Source BioScience under the Listing Rules and therefore requires and is conditional, inter alia, upon approval by its Shareholders. Accordingly, a General Meeting has been convened for this purpose and will be held at 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX on 14 August 2015 at 10.00 a.m.
Copies of the Circular may be obtained free of charge at the offices of the Company at 1 Orchard Place, Nottingham Business Park, Nottingham, NG8 6PX during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) from the date of the Circular until 14 August 2015 and on the Company's website at www.sourcebioscience.com under the Investor Relations, General Meetings section. The Circular has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.
Expected Timetable of Principal Events
General Meeting | 14 August 2015 |
Expected date of Admission and commencement of dealingsin the New Ordinary Shares on the London Stock Exchange | 17 August 2015 |
Expected date of Completion of the proposed acquisition | 17 August 2015 |
Note:
The times and dates set out in the expected timetable of principal events above may be adjusted by Source BioScience (in consultation with N+1 Singer), in which event details of the new times and dates will be notified to the UK Listing Authority and the London Stock Exchange and will be announced via a Regulatory Information Service.
For further information please contact:
Source BioScience plc
Dr Nick Ash, CEO
Tel: +44 (0) 115 973 9010
Email: [email protected]
www.sourcebioscience.com
Related Shares:
SBS.L